| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |